Tilray Brands (TLRY) EBT (QoQ) (2017 - 2026)
Tilray Brands (TLRY) EBT (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -120.83% |
| Feb 28, 2026 | 41.80% |
| Nov 30, 2025 | -5,076.55% |
| Aug 31, 2025 | 99.94% |
| May 31, 2025 | -75.82% |
| Feb 28, 2025 | -851.87% |
| Nov 30, 2024 | -146.52% |
| Aug 31, 2024 | 21.48% |
| May 31, 2024 | 60.13% |
| Feb 29, 2024 | -117.61% |
| Nov 30, 2023 | -1.98% |
| Aug 31, 2023 | 56.49% |
| May 31, 2023 | 90.74% |
| Feb 28, 2023 | -1,544.98% |
| Nov 30, 2022 | -25.20% |
| Aug 31, 2022 | 87.31% |
| May 31, 2022 | -1,011.45% |
| Feb 28, 2022 | 40,094.44% |
| Nov 30, 2021 | 100.42% |
| Aug 31, 2021 | -114.20% |